SCHEMBL7204759

SCHEMBL7204759

O=C(OCC1OCOC1COC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPK1 P28482 2/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CHRNB2 P17787 1/20 0.49
CHRNA5 P30532 1/20 0.49
CHRNA7 P36544 1/20 0.49
CHRNA4 P43681 1/20 0.49
KMT2A Q03164 2/20 0.49
HIF1A Q16665 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
NPC1 O15118 1/20 0.48
LMNA P02545 1/20 0.47
PPM1B O75688 1/20 0.46
TSHR P16473 1/20 0.45
MEN1 O00255 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid 2,3-Epoxypropyl Ester SCHEMBL14570069 0.81 NPC1 (0.56) TDP1MAPK1CHRNB2CHRNA5CHRNA7
Benzoic Acid 2,3-Epoxypropyl Ester SCHEMBL133986 0.81 NPC1 (0.56) TDP1MAPK1CHRNB2CHRNA5CHRNA7
Benzoic Acid 2,3-Epoxypropyl Ester SCHEMBL5604855 0.81 NPC1 (0.56) TDP1MAPK1CHRNB2CHRNA5CHRNA7
SCHEMBL172378 0.81 TDP1 (0.52) TDP1ALDH1A1MAPK1CHRNB2CHRNA5
Benzoic Acid 2,3-Epoxypropyl Ester SCHEMBL21245419 0.81 NPC1 (0.56) TDP1MAPK1CHRNB2CHRNA5CHRNA7
SCHEMBL26805624 0.80 PPM1B (0.47) TDP1ALDH1A1MAPK1POLBGAA
SCHEMBL22522070 0.80 CHRNB2 (0.47) TDP1ALDH1A1MAPK1POLBGAA
SCHEMBL12959081 0.79 ALDH1A1 (0.57) TDP1ALDH1A1MAPK1POLBGAA
SCHEMBL6273371 0.79 ALDH1A1 (0.53) TDP1ALDH1A1MAPK1POLBGAA
Benzoic Acid 2,3-Epoxypropyl Ester SCHEMBL6359889 0.79 NPC1 (0.55) TDP1CHRNB2CHRNA5CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0632028-B1 OPTICALLY ACTIVE 2-NITROIMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATE FOR PRODUCING THE SAME POLA CHEM IND INC (JP) 2003-04-02 EP disclosed
US-5532380-A RADIOSENSITIZERS FOR CANCER THERAPY; PURE ENANTIOMORPHS POLA CHEMICAL INDUSTRIES, INC. (JP) 1996-07-02 US disclosed
EP-0632028-A1 OPTICALLY ACTIVE 2-NITROIMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATE FOR PRODUCING THE SAME POLA CHEMICAL INDUSTRIES, INC. (JP) 1995-01-04 EP disclosed
EP-0072027-B1 ANTIVIRAL COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1988-05-18 EP disclosed
EP-0072027-A1 Antiviral compounds THE WELLCOME FOUNDATION LIMITED (GB) 1983-02-16 EP disclosed